3 sources·Health

Breakthrough Asthma Treatment Marks a New Era in Care

A new injectable treatment for asthma and COPD shows promise as the first major advancement in 50 years.

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).
Reliable
The underlying sources consistently report facts with minimal bias, demonstrating high-quality journalism and accuracy.
Balanced
The underlying sources are either a balanced mix of left and right or primarily centrist.
Subscribe to unlock this story

We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!

Get Started

No highlights available for this story.

Updated: Nov 27th, 2024, 10:11 PM ET

Summary

A summary of the key points of this story verified across multiple sources.

Researchers have developed a groundbreaking treatment for asthma and COPD. Benralizumab, an injectable medication, targets eosinophils to reduce lung inflammation and improve patient outcomes. A study indicates it is more effective than standard steroid treatments, potentially revolutionizing care for millions. With a significant reduction in treatment failures observed, doctors are optimistic about its future, although further trials and assessments are needed before widespread use. This breakthrough highlights a much-needed advancement in lung health treatments after decades of stagnation.

Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.

No center-leaning sources available for this story.